PharmaNet Development Group, a provider of pharmaceutical services to biotechnology, generic drug and medical device companies, has promoted Jeffrey Freitag, M.D., senior vice president of PharmaNet Consulting, to chief medical officer.
Dr. Freitag will be the senior medical representative and guide physicians involved in phase I through phase III clinical trials. He will retain his current responsibilities heading the team of regulatory and pharmaceutical consultants.
Dr. Freitag has worked in the pharmaceutical industry for more than 25 years, including positions as vice president of clinical drug development at The Liposome Company and vice president of R&D at Bone Care International. He is board certified in Internal Medicine and Nephrology.